Legislative Activity

The Forgotten Funds Act mandates the rescission of all unobligated discretionary funds set aside by Congress for fiscal year 2021 and prior years. This returned money will be permanently transferred to the Treasury's general fund. The sole purpose of these recovered funds is to reduce the national deficit.

The Securing Migration, Addressing Reform, and Talent Retention (SMART) Act overhauls the U.S. immigration system by eliminating the Diversity Visa Program and establishing a new points-based system for employment-based immigration. The bill also reforms family-sponsored immigration by redefining "immediate relatives" and creating a new non-working visa category for parents of adult citizens. Furthermore, it sets new annual caps for refugee admissions and reforms the allocation and release of H-1B specialty visas.

This bill aims to significantly reform the Medicare Advantage (MA) program, primarily starting in 2028. Key changes include mandating capitated payments for most providers, restricting how diagnosis data is used for payment adjustments, and implementing automatic enrollment into the lowest-premium MA plans. Furthermore, the legislation introduces a three-year enrollment lock-in period for new MA enrollees.

The Manifest Modernization Act of 2025 updates federal requirements for public disclosure of cargo manifest information for all incoming ships, vehicles, and aircraft. This bill mandates that manifests include more specific details, such as the Harmonized Tariff Schedule subheading and precise country of origin data for all cargo. These new disclosure standards will take effect thirty days after the Act is signed into law.

This bill suspends the production of pennies and nickels for 10 years, while allowing the Treasury Secretary to continue making them for coin collectors under specific guidelines. It also requires the Comptroller General to study the effects of this suspension, including potential savings and the impact of rounding cash transactions, and report findings to Congress within three years to determine if the suspension should continue, become permanent, or be reversed. Pennies and nickels will remain legal tender during this time.

This bill directs the Secretary of Health and Human Services to establish drug adherence guidelines, using AI and machine learning, to achieve a 90% adherence rate for Medicare Part B and D drugs. These guidelines will prioritize the use of generic and biosimilar drugs when appropriate.

The DEBT Act requires the Secretary of the Treasury to testify before Congress regarding planned "extraordinary measures" whenever the federal debt limit is approaching. This legislation mandates that the Secretary provide a detailed explanation of these measures, their administrative costs, and the financial implications of any subsequent debt limit adjustments.

The Healthy Technology Act of 2025 amends the Federal Food, Drug, and Cosmetic Act to authorize artificial intelligence and machine learning systems to prescribe medication. To qualify, these technologies must receive FDA approval and comply with specific state-level regulations.

The Paws Off Act of 2025 mandates that all food products containing xylitol include a clear warning label regarding the substance's toxicity to dogs. This legislation directs the FDA to establish formal labeling requirements within one year to help pet owners identify and avoid potential poisoning risks.

The JFK Act of 2025 mandates the full, unredacted public disclosure of all remaining federal records related to the assassination of President John F. Kennedy. Within 30 days of enactment, specified federal agencies must release these documents, overriding all previous legal restrictions, secrecy orders, and non-disclosure directives. Additionally, the Attorney General is required to petition courts to unseal any relevant records currently held under grand jury or judicial secrecy.

The Maintaining Innovation and Safe Technologies Act requires the Secretary of Health and Human Services to issue guidance by January 1, 2027, clarifying Medicare payments for remote monitoring devices utilizing artificial intelligence. This includes devices like continuous glucose monitors that transmit data to healthcare providers for patient care. The guidance aims to address how Medicare will handle payments for these innovative technologies.